Discover Digital Health Startups in Omics Related Diagnosis

The category, Omics Related Diagnosis, contains 209 Digital Health ventures. The total venture volume has expanded at a CAGR of 4.5% over the past 5 years. The ventures have an average venture maturity score of 54.6.

In total, $10.42B of Digital Health venture capital has been raised across 519 funding deals.

Last Updated: December 02, 2023

Ventures

ShowEntries

Startup	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding	Track
3D Medicine (思路迪)	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Series H	$ 229.02 M	Toggle
Color Genomics	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series E	$ 100.00 M	Toggle
HaploX (海普洛斯)	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Series D	$ 100.00 M	Toggle
Tempus	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series H	$ 275.00 M	Toggle
MiRXES (觅瑞早筛)	Omics Related Diagnosis	Singapore	xyrsttzsas	$ 123.46 B	Series C1	$ 10.00 M	Toggle
Freenome	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series D1	$ 290.00 M	Toggle
BostonGene	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series B	$ 150.00 M	Toggle
Creative Biosciences (康立明生物)	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Series D	$ 87.02 M	Toggle
Singlera Genomics (鹍远基因)	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Series B2	$ 44.79 M	Toggle
Delfi Diagnostics	Omics Related Diagnosis	United States	xyrsttzsas	$ 123.46 B	Series B	$ 225.00 M	Toggle

Showing 1 to 10 of 209 entries